Neurology

Diagnosis and treatment of multifocal motor neuropathy.

Curr Treat Options Neurol. 2008 Mar;10(2):103-7.


Kaji R.

Ryuji Kaji MD, PhD Department of Neurology, Hospital of the University of Tokushima, 2-chome 5-1, Kuramotocho, Tokushima City, Tokushima, 770-8503, Japan. rkaji@clin.med.tokushima-u.ac.jp.

Multifocal motor neuropathy (MMN) is a unique disease mimicking motor neuron disease, but it is treatable with intravenous immunoglobulins. Anti-GM1 IgM antibody titers are not sensitive enough to predict the outcome. Electrodiagnosis is essential for the diagnosis of MMN. Conduction block has been suggested as the best diagnostic marker, but it is not found in all treatable cases. Activity-dependent conduction changes, as revealed by comparing conduction before and after maximal voluntary contraction of the muscle, are a convenient and promising tool. Treatment options include various immunosuppressants (including cyclophosphamide), but there has not been ample evidence in favor of any of these agents in randomized controlled trials. Intravenous immunoglobulins remain the mainstay for treating MMN.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100